pharmacopeia

Mechanism of action

Sourced from openFDA

Mechanism-of-action class: Stool Bulking Activity.

Indications

Sourced from openFDA
  • Uses For the temporary relief of burning and irritation due to dryness of the eye For the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun For use as a protectant against further irritation or to relieve dryness of the eye

Dosage & administration

Sourced from openFDA

Directions Instill 1 or 2 drops in the affected eye(s) as needed.

Warnings & precautions

Sourced from openFDA

For external use only Do not use If solution changes color or becomes cloudy If you are sensitive to any ingredient in this product When using this product To avoid contamination do not touch tip of container to any surface Replace cap after using Stop use and ask a doctor if You experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
23,587 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Drug Ineffective7,82933%
  2. 2Oral Herpes2,42210%
  3. 3Condition Aggravated2,0108.5%
  4. 4Drug Administration Error1,7867.6%
  5. 5Eye Irritation1,0554.5%
  6. 6Eye Pain1,0104.3%
  7. 7Incorrect Drug Administration Duration8063.4%
  8. 8Off Label Use7743.3%
  9. 9Pain7463.2%
  10. 10Herpes Simplex7093.0%
  11. 11Wrong Technique In Product Usage Process7093.0%
  12. 12Macular Degeneration6722.8%
  13. 13Incorrect Product Administration Duration6182.6%
  14. 14Product Quality Issue6082.6%
  15. 15Headache6022.6%

Literature

View JSON

Recent PubMed references pinned to Glycerin as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 241 ClinicalTrials.gov registrations naming Glycerin as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Glycerin work?
Mechanism-of-action class: Stool Bulking Activity.
What is Glycerin used for?
According to FDA labeling, Glycerin carries indications including: Uses For the temporary relief of burning and irritation due to dryness of the eye For the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun For use as a protectant against further irritation or to relieve dryness of the eye. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Glycerin?
Glycerin is classified as Enemas, Other drugs for constipation, Non-Standardized Chemical Allergen, Stool Bulking Activity, Cell-mediated Immunity, Emollient Activity, Increased Histamine Release, Increased IgG Production, Increased Large Intestinal Motility, Stimulation Large Intestine Fluid/Electrolyte Absorption.
What are the brand names for Glycerin?
Glycerin is marketed under brand names including Abreva Rapid Pain Relief, Blink Dry Eye, Chloraseptic Max Spray, Oasis Tears, Pedia-Lax Liquid Glycerin Suppositories, Pretz, ProcalAmine 3, Recticare Wipes.
Note. Data for glycerin is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients